Volume 19, Issue 2 (June-July 2015)                   J Qazvin Univ Med Sci 2015, 19(2): 11-20 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sofiabadi M, Haghdoost-Yazdi H, Mahmudi M, Pri H, Dargahi T, Yaghubidust M. Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats. J Qazvin Univ Med Sci. 2015; 19 (2) :11-20
URL: http://journal.qums.ac.ir/article-1-1814-en.html
, Email: hhaghdoost@gmail.com
Abstract:   (3274 Views)

  Background: Nuclease and caspase enzymes activities which promote death signals and lead to apoptosis are dependent to potassium ions.

  Objective: The aim of this study was to determine the effect of 4-aminopyridine (4-AP) potassium channel blocker on the animal model of Parkinson's disease.

  Methods: This experimental study was performed in Qazvin University of Medical Sciences, 2013. Male Rats were received different doses of 4-AP twice daily from half an hour before injection of 6-hydroxydopamine (6-OHDA) to 7 or 15 days after that. 6-OHDA was injected into medial forebrain bundle (MFB) in acute model groups and into striatum in chronic model groups. The severity of Parkinsonism was assessed by standard behavioral methods. Data were analyzed using Kruskal-Wallis and Mann Whitney U tests.

  Findings: In acute model groups, administration of 0.5 mg/kg 4-AP (n=9) had no remarkable effect on behavioral symptoms, but 1 mg/kg 4-AP (n=8) significantly reduced the severity of apomorphine-induced rotations and improved motor learning in rotarod test. In chronic model groups, although 1 mg/kg 4-AP (n=7) significantly reduced the severity of rotations and improved motor learning, but 0.5 mg/kg 4-AP (n=8) was more effective.

  Conclusion: Pretreatment with 4-AP can reduce 6-OHDA-induced dopaminergic neuron death. Since the chronic model of 6-OHDA is more similar to Parkinson's disease in human, the low dose of 4-AP is recommended for treatment of this disease.

 

  Keywords: Parkinson Disease , Potassium Channel Blockers , Oxidopamine , Substantia Nigra

  Citation: Sofiabadi M, Haghdoost-Yazdi H, Mahmudi M, Piri H, Dargahi T, Yaghubidust M. Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats. J Qazvin Univ Med Sci. 2015 19 (2): 11-20.

Full-Text [PDF 256 kb]   (833 Downloads)    
Type of Study: Research | Subject: Cognitive Neuroscience

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | The Journal of Qazvin University of Medical Sciences

Designed & Developed by : Yektaweb